These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 15144911

  • 21. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA.
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [Abstract] [Full Text] [Related]

  • 22. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C, Federico A, Masarone M, Torella R, Blanco Cdel V, Persico M.
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
    Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K, Nagano Interferon Treatment Research Group.
    J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Hosaka T, Kobayashi M, Kumada H.
    J Gastroenterol; 2004 Jul; 39(5):455-60. PubMed ID: 15175944
    [Abstract] [Full Text] [Related]

  • 32. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P, Maouzi AB, Mänhardt LB, Bickeböller H, Ramadori G, Mihm S.
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T.
    Hepatology; 2005 Jan; 41(1):106-14. PubMed ID: 15619235
    [Abstract] [Full Text] [Related]

  • 38. [The course of bronchial asthma in adults. Factors of importance for the annual decline of lung function].
    Ulrik CS, Backer V, Dirksen A.
    Ugeskr Laeger; 1993 Mar 22; 155(12):867-71. PubMed ID: 8480383
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reversibility of pulmonary function after inhaling salbutamol in different doses and body postures in asthmatic children.
    Visser R, Kelderman S, de Jongh FH, van der Palen J, Thio BJ.
    Respir Med; 2015 Oct 22; 109(10):1274-9. PubMed ID: 26341548
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.